AKR1B1 is a cytosolic enzyme traditionally studied in the context of diabetes and metabolic disease due to its role in the polyol pathway, where it catalyzes the reduction of glucose to sorbitol [3]. This evidence concerns the gene AKR1B1 and diabetes mellitus.